JDJeffrey Jeswant Dillon

Jeffrey Jeswant Dillon

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jeffrey Jeswant Dillon has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Optimizing Fluid Resuscitation Strategies: A Network Meta-analysis of Effectiveness and Safety for Hemorrhagic Shock Patients in Emergency Settings

    by Fan Maitri Aldian, Visuddho Visuddho, Michelle Vanessa Anggarkusuma, Jesphine Arbi Wijaya, Anthony Camilo Lim, Galen Chandrawira, Yan Efrata Sembiring, Bambang Pujo Semedi, Jeswant Dillon

    Introduction: Hemorrhagic shock is a life-threatening condition and remains a leading cause of death worldwide. Current European guidelines lack recommendations for one fluid type over another in the management of hemorrhagic shock. This study explores the effectiveness and safety of colloids and crystalloids in resuscitation of hemorrhagic shock patients. Methods: We conducted a systematic search in PubMed, Cochrane Cenral Register of Controlled Trials (CENTRAL), Scopus, Web of Science, ProQuest, and Cumulative Index to Nursing and Allied Health Literature (CINAHL) up to January 3, 2024. We performed data analyses using Rstudio v.4.4.1 in Frequentist network meta-analysis with DerSimonian-Laird random-effects model. Subgroup and network meta-regression analyses was also performed in Bayesian methods. We analyzed safety aspects using meta-proportions with generalized linear mixed models models. Results: A total of 3,693 patients from 23 randomized controlled trials were included in this study. Synthetic colloid demonstrated the lowest mortality rate (odds ratio 0.37, 95% CI, 0.15-0.93; P-score = .94) with the lowest fluid input requirement (mean difference -1.02; 95% CI, -1.62 to -0.41; P-score = .75). Subgroup and network meta-regression analysis revealed none of the covariates significantly influenced these two outcomes. Regarding safety aspects, isotonic crystalloid caused the most diverse adverse events, with acute respiratory distress syndrome (prop = 0.067) and overload syndrome (prop = 0.063) being the most common adverse events. Conclusion: This study provides robust evidence favoring the initial use of synthetic colloid in the management of patients with hemorrhagic shock.


  • Open Access

    Right Ventricular Dimension is a Predictor of Inhospital Mortality after Surgery in Late Presenting Mitral Valve Disease

    by Zulfayandi Pawanis, Yan Efrata Sembiring, Oky Revianto Sediono Pribadi, Jeffrey Jeswant Dillon

    Introduction: Mitral valve disease remains a major global heart-related issue affecting developed and developing countries. This study aimed to report overall mortality and evaluate perioperative factors contributing to postoperative inhospital mortality after isolated mitral valve replacement (MVR). Methods: This research was a retrospective study. The data were collected from patients who underwent primary, isolated, and elective MVR between January 2020 and July 2024. The primary outcome was inhospital mortality, and the secondary outcome was identifying factors associated with postoperative mortality. Receiver operating curve (ROC) analysis with area under the curve (AUC) was performed to identify risk factors and to determine the prognostic values. Results: A total of 81 patients were analyzed (mean age: 45.7 ± 13.2 years; body mass index: 21.8 ± 3.9 kg/m²). Of these, 55 were female, and over half of the patients presented with atrial fibrillation and pulmonary hypertension. Preoperative echocardiography showed left atrial dilatation in 98% of patients. The overall mortality rate was 14.8%. Multiple regression analysis indicated right ventricular diameter at base (RVDB) as a significant predictor of inhospital mortality (hazard ratio = 3.798; 95% confidence interval [CI] 1.150–12.541; P = 0.029). ROC analysis showed that an RVDB 3.05 cm predicted postoperative mortality with fairly good accuracy (AUC 0.769; 95% CI 0.632–0.905; P = 0.004). Conclusion: In patients undergoing MVR for mitral valve disease, the right ventricular diameter at baseline is an independent risk factor for inhospital mortality and may serve as a predictive marker for postoperative mortality.

  • Open Access

    Lung Cancer: A Literature Review

    by Yan Efrata Sembiring, Wiwin Is Effendi, Jeffrey Jeswant Dillon, Heroe Soebroto, Dhihintia Jiwangga Suta Winarno, Puruhito Puruhito, I Gusti Agung Made Adnyanya Putra, Abed Nego Okthara Sebayang, Sri Pramesthi Wisnu Bowo Negoro

    Lung cancer is a cancer whose onset starts in the lungs where there is an abnormal cell growth that is very fast and uncontrolled. The abnormal cell growth is triggered by deoxyribonucleic acid (DNA) damage, including deletions in the DNA section, inactivation of tumor suppressor genes, activation of proto-oncogenes to oncogenes, the absence of apoptosis, and the activity of the telomerase enzyme. Lung cancer is initiated by oncogeneous activity and inactivation of tumor suppressor genes. Oncogenes are genes that help cells grow and divide and are believed to cause a person to develop lung cancer. In general, lung cancer is divided into two types, namely non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). World Health Organization (WHO) classifies lung cancer based on histopathology into 4 major cell types, namely SCLC, NSCLC which includes adenocarcinoma, squamous cell carcinoma (SCC), and large cell carcinoma (LCC). The difference between the two is that SCLC has a higher aggressiveness than NSCLC. Cancer treatment is based on the type, size, location and stage of the cancer, as well as the patient's overall condition.


  • Open Access

    Does endoscopic thoracic sympathectomy improve the quality of life of patients with primary hyperhidrosis? A single center retrospective review

    by Ahmad Farouk Musa, Khit Kar Hui, Jeswant Dillon, Rusli Bin Nordin

    Background: Endoscopic thoracic sympathectomy (ETS) is renowned as an effective surgical treatment for primary hyperhidrosis (PHH) and believed to improve patients’ quality of life (QOL). This study aimed to evaluate the quality of life (QOL) of patients with PHH after ETS compared to before ETS, and to determine whether compensatory sweating (CS) affects QOL of patients. Methods: This is a single-centre retrospective review of patients who had undergone ETS at the National Heart Center [Institut Jantung Negara (IJN)], Malaysia. In total, 62 patients from January 2014 to December 2018 were recruited. Medical records were first reviewed for all relevant data, prior to making telephone interview to administer the questionnaire. A modified questionnaire with validated components was used to assess the patients’ QOL. Patient satisfaction, symptom resolution, recurrence and occurrence of CS were also asked during the interview. Data were analysed using IBM SPSS Statistics 25.0. Results: A total of 46 patients (response rate: 74.2%) completed the questionnaire, with 95.7% reporting improvement in the total QOL score (Mean difference = 113.54, SD=70.79, 95% CI = 95.52 – 134.57, p<0.001). There was remarkable symptom resolution for palmar HH as 97.8% reported dry hands, whereas majority of patients with palmar-plantar HH reported persistent sweating from feet HH. CS rate was 89.1%. In terms of severity of CS, 6 (14.6%) reported mild, 17 (41.5%) moderate, and 18 (43.9%) had severe CS. The severity of CS as well as the number of locations have a significant effect on the QOL reported (p=0.022 and p=0.008, respectively). Conclusion: ETS is an effective treatment for PHH in improving the QOL of patients, even long term. The occurrence of CS did not affect the QOL, but severity of CS and number of locations involved in CS affect the QOL of patients.